Innosuisse: how it works and who can access it

Innosuisse is the Swiss federal agency for the promotion of innovation. Its purpose is clear: to turn research into products, services and companies that stand up in the market. For a founder or an innovative SME it is one of the most attractive instruments, because it offers non-dilutive funding — it does not ask for shares in exchange for its support. But it does not fund generic ideas: it funds projects with real innovation content and a credible scientific partner.

What Innosuisse does

Innosuisse is not a fund that hands out cash to whoever asks for it. It is an agency that supports innovation with different instruments depending on the stage you are at:

Innovation projects: the heart of its activity. A company collaborates with a Swiss research institution (universities, federal institutes of technology, universities of applied sciences) to develop something new. Innosuisse generally covers the costs of the scientific part; the company puts in its own contribution.
Startup coaching: structured programmes for founders who want to build a scalable business, with experienced mentors.
Mentoring and networking: access to expertise, contacts and internationalisation programmes.
Innovation cheques and feasibility studies: smaller amounts to test the feasibility of an idea before launching a real project.
Programmes for access to markets and to Europe, useful when the ambition goes beyond Switzerland’s borders.

The common thread is always the same: science-based innovation, with expected economic impact.

Who can access it

The requirements change depending on the instrument, but some principles apply in general:

You need a roots in Switzerland: companies with a registered office or activity in the country, and Swiss research partners for innovation projects.
You need demonstrable innovation content: an incremental improvement or the adoption of existing technology is not enough. There must be a new element, with a technical risk to overcome.
You need market potential: Innosuisse wants to see that, if the project succeeds, economic value arises from it — revenue, employment, competitiveness.
For innovation projects, the logic is collaboration: the company brings the problem and the market, the research institution brings the scientific expertise.

Very young startups often begin with coaching and the lighter instruments; companies with an academic partner aim directly at innovation projects.

What evaluators really look for

Whoever examines an Innosuisse application looks at three things, always the same:

Novelty and scientific rigour: what is the leap relative to the state of the art? Why is research needed and not just development?
Economic impact: who will buy the result, how big is the market, how you reach the customers. The numbers must be built from the bottom up, not dropped in as “1% of a huge market”.
Quality of execution: team, realistic milestones, consistency between objectives and budget, risk management.

A dossier that is technically strong but weak on impact gets rejected just as much as one with a fine market story but no real innovation. The two sides have to hold up together.

The most common mistakes

Confusing development with innovation: if there is no technical-scientific risk, the project is not fundable.
A research partner chosen at the last minute and poorly integrated: the collaboration must be substantial, not for show.
A market described with adjectives instead of with data.
Budget and milestones inconsistent with the stated ambitions.
Underestimating the timing: preparing a solid application takes weeks, not days.

Innosuisse within a broader strategy

Innosuisse is rarely the only lever. It often combines with private capital (business angels, venture capital) and with other grant funding instruments, including European ones such as the EIC Accelerator or Horizon Europe. Innosuisse’s non-dilutive funding extends the runway without giving up shares; private capital accelerates growth. Planning the order and the combination of these instruments is part of the financial strategy of an innovative company, not a detail.

In summary

Innosuisse supports Swiss innovation with non-dilutive funding.
Innovation projects require a Swiss research partner and genuine scientific content.
Three axes count: novelty, market impact, quality of execution.
The bottleneck is not the funds, it is the quality of the dossier.

How we help you

We help companies and startups understand whether and for which Innosuisse instruments they are eligible, choose the right research partner and build a dossier with the evaluator’s logic — novelty, impact, credible numbers. It starts with a free grant readiness check. Assess your options.